Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
批准号:
10790511
负责人:
Jianjun Pan
金额:
$14.17万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-08 至 2025-08-31
关键词:
AmericanAmyloidAtomic Force MicroscopyBiological AssayCalcium ionCardiolipinsCell physiologyCellsCholesterolCognitiveDataDiseaseElasticityExtravasationFDA approvedFingerprintFutureGanglioside GM1Genetic DiseasesGoalsHuntington DiseaseHuntington geneInclusion BodiesInvestigationLateralLipid BilayersLipidsLiquid substanceMechanicsMediatingMembraneMembrane LipidsMicroscopicMolecularMolecular ConformationMorphologyMotorNeurodegenerative DisordersNeuronsPathogenesisPenetrationPeptidesPermeabilityPharmaceutical PreparationsPilot ProjectsPropertyProteinsRaman Spectrum AnalysisResearchResolutionRiskRoleShapesSpecificitySpectrum AnalysisStretchingStructureSymptomsSynaptic MembranesToxic effectToxinVertebral columnVesicleage relatedaspiratebasebiophysical techniquesbiophysical toolsexperimental studylipid Imembrane assemblymisfolded proteinmitochondrial membranemonomermutantnanonanomechanicsnanoscaleneuron losspolyglutamineprotein aggregationrelease of sequestered calcium ion into cytoplasmunilamellar vesicle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Huntington’s disease (HD) is a devastating neuronal disorder caused by the mutant huntingtin (Htt) protein with
an abnormal expansion of the polyglutamine (polyQ) tract. Mutant Htt has an intrinsic propensity of forming
prefibrillar and fibrillar aggregates. Although aggregates-dictated toxicity has been widely suggested for a
plethora of neuronal disorders, the mechanism of how amyloids cause medium spiny neuronal death in HD
remains unclear. Although fibrillar aggregates are commonly found in plagues and inclusions bodies, small
oligomers are now considered as the dominant molecular toxins underlying many neurodegenerative diseases.
Based on the oligomer hypothesis and the apparent role of membrane assemblies in amyloid toxicity, we
hypothesize that nanoscale oligomers of mutant Htt are responsible for modulating membrane properties,
leading to progressive loss of cellular functions such as unregulated flux of calcium ions and abnormal shape
transformation of synaptic and mitochondrial membranes. We further hypothesize that oligomer-membrane
interactions are lipid specific. Because lipid profile is cell dependent and age dependent, lipid specificity could
serve as a plausible cause for variable cell vulnerability to the same amyloid species. Although polyQ-
membrane interactions have been widely studied, a mixture of prefibrillar and fibrillar aggregates are often
present. Consequently, it is challenging to distinguish which aggregated species is responsible for the
observed effects on membrane properties. We will first separate soluble polyQ oligomers from fibrils and
monomers. We will then use experimental approaches to investigate oligomer-membrane interactions. In Aim
1, we will seek to determine the effects of nanoscale oligomers on microscopic and nanoscopic properties of
lipid membranes. Based on the significance of specific lipids in HD pathogenesis, we will prepare lipid
membranes with defined lipid compositions. Our lipid-dependent studies will elucidate the role of specific lipids
in governing oligomer toxicity. In Aim 2, we will conduct Raman spectroscopy experiments to investigate
atomic-level changes of lipid membranes. Raman spectral data will unveil how oligomers perturb the lipid i)
intra-chain conformational order and ii) inter-chain packing order. A combination of biophysical tools will be
employed in this project, including high-resolution atomic force microscopy (AFM), AFM-based force
spectroscopy, vesicle leakage assay, micropipette aspiration, and Raman spectroscopy. The biophysical
approaches elaborated in this project can to transferred to investigations of an array of oligomers formed by
different amyloidogenic proteins. Therefore, our research will pave the way for future studies aimed at
elucidating molecular bases of oligomer-governed toxicity.
1/1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: